CureVac NV
XBER:5CV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CureVac NV
XBER:5CV
|
DE |
|
E
|
EDP Energias de Portugal SA
ELI:EDP
|
PT |
|
C
|
Chargeurs SA
F:GET
|
FR |
|
E
|
Estee Lauder Companies Inc
VSE:ESLA
|
US |
|
T
|
Tharisa PLC
JSE:THA
|
CY |
|
Cooper Companies Inc
F:CP60
|
US |
|
Toughbuilt Industries Inc
F:36Q
|
US |
|
W
|
Wacker Neuson SE
XBER:WAC
|
DE |
|
Nextera Energy Inc
NYSE:NEE
|
US |
|
Societe de Services de Participations, de Direction et d'Elaboration SA
XBRU:SPA
|
BE |
|
Legrand SA
PAR:LR
|
FR |
|
M
|
Maple Leaf Foods Inc
OTC:MLFNF
|
CA |
|
Newcap Holding A/S
F:25N
|
DK |
|
O
|
Odfjell Drilling Ltd
XMUN:OD3
|
BM |
|
A
|
Aeroports de Paris SA
XBER:W7L
|
FR |
|
M
|
Manz AG
F:M5Z
|
DE |
|
E
|
eHealth Inc
XBER:M5V
|
US |
|
Trisura Group Ltd
TSX:TSU
|
CA |
|
Y
|
Yum! Brands Inc
XBER:TGR
|
US |
|
V
|
Versigent PLC
NYSE:VGNT
|
CH |
|
Textron Inc
NYSE:TXT
|
US |
|
Industrivarden AB
OTC:IDDTF
|
SE |
|
C
|
CommScope Holding Company Inc
F:CM9
|
US |
Bankruptcy Probability
CureVac NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
CureVac NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
CureVac NV
NASDAQ:CVAC
|
1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
CureVac NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, CureVac NV has total debt of 30.3m EUR. This includes both short-term (0 EUR) and long-term (30.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
